BrosMed Medical Co., Ltd. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Tri-Wedge PTA Scoring Balloon Dilatation Catheter. “This represents yet another significant achievement in our effort to introduce BrosMed’s broad portfolio into the US market”, comments Scott J. Addonizio, Chief Operating Officer.
Visit us at Booth 1710. We are delighted to meet you soon in Washington! See you there!
Sept. 30th, 2024 – BROSMED, an industry-leading multinational group in […]
We are pleased to announce that BrosMed team will be […]
BrosMed Medical is delighted to participate in the ESC Congress […]
2024 August 1st – BrosMed Medical is pleased to announce […]
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on […]
Join us for this insightful session to hear about the tips and tricks from well-known professors on the successful practice on endovascular treatment!
Visit our booth to gain new insights into BrosMed Complex PAD & AVF tools: Tri-Wedge™ PTA Scoring Balloon Dilatation Catheter & Tiche™ High Pressure PTA Balloon Dilatation Catheter.
BrosMed Medical is thrilled to invite you to join us at EuroPCR 2024 in Paris from May 14-17, 2024 at Palais des Congrès, Paris.
BrosMed Medical is delighted to participate in the PAIRS 2024 Congress from February 10th to 13th in Dubai, UAE. We can’t wait to engage with the masters and partners there, as well as showcase our professional toolkit for complex PCI and AVF&PAD solutions.
This certification confirms BrosMed’s compliance with the high standards and regulatory requirements of most leading countries in the world.
